Form 4: Dyne Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4
Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 7, 2024, Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 2,273 shares of common stock at a weighted average price of $25.85.
- The sale was to satisfy tax withholding obligations related to the vesting of restricted stock units granted on November 15, 2023.
- Following the transaction, Scalzo beneficially owns 121,955 shares, including 118,605 unvested RSUs.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that an executive sold shares to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 11/15/2023 | Date of restricted stock units grant to the Reporting Person |
| 03/07/2024 | Date of transaction (stock sale) |
| 03/11/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.